Prevalence and risk factors of kidney stone disease in population aged 40–70 years old in Kharameh cohort study: a cross-sectional population-based study in southern Iran
Background Kidney stone is the major cause of morbidity, and its prevalence is increasing in the world. This study aimed to assess the prevalence and risk factors of kidney stone in the adult population of southern Iran based on the data of the Kharameh Cohort Study. Methods This cross-sectional stu...
Saved in:
Published in | BMC urology Vol. 22; no. 1; pp. 205 - 9 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central
19.12.2022
BioMed Central Ltd BMC |
Subjects | |
Online Access | Get full text |
ISSN | 1471-2490 1471-2490 |
DOI | 10.1186/s12894-022-01161-x |
Cover
Abstract | Background
Kidney stone is the major cause of morbidity, and its prevalence is increasing in the world. This study aimed to assess the prevalence and risk factors of kidney stone in the adult population of southern Iran based on the data of the Kharameh Cohort Study.
Methods
This cross-sectional study was conducted on 10,663 individuals aged 40–70 years old, using the baseline data of Kharamah cohort study, which started in 2014. Among all participants, 2251 individuals had a history of kidney stone. The participants’ demographic characteristics, behavioral habits, and the history of underlying diseases were investigated. The crude and Age Standardized Prevalence Rate of kidney stones was calculated. Also, logistic regression was used to identify the predictors of kidney stone. To check the goodness of fit index of the model, we used the Hosmer–Lemeshow test. All analyses were performed in STATA software.
Results
The prevalence of kidney stone was estimated 21.11%. Also, the Age Standardized Prevalence Rate in men and women was calculated 24.3% and 18.7%, respectively. The mean age of the participants was 52.15 years. Higher prevalence of kidney stone was seen in women aged 40–50 years (40.47%,
p
= 0.0001) and moderate level of social economic status (31.47%,
p
= 0.03), men with overweight (44.69%,
p
< 0.0001) and those in a very high level of social economic status (35.75%,
p
= 0.001). The results of multiple logistic regression showed that the chance of having kidney stone was 1.17 times higher in diabetic individuals, 1.43 times higher in hypertensive individuals, 2.21 times higher in individuals with fatty liver, and 1.35 times higher in individuals with overweight. The level of socio economic status, male sex, and age were the other factors related to kidney stone.
Conclusion
In this study, underlying diseases such as fatty liver, diabetes, and hypertension as well as age, male sex, overweight, and high social economic status were identified as important risk factors for kidney stone. Therefore, identifying individuals at risk of kidney stone and providing the necessary training can greatly help to reduce this disease. However, health policymakers should prepare preventive strategies to reduce the occurrence of kidney stone. |
---|---|
AbstractList | Background Kidney stone is the major cause of morbidity, and its prevalence is increasing in the world. This study aimed to assess the prevalence and risk factors of kidney stone in the adult population of southern Iran based on the data of the Kharameh Cohort Study. Methods This cross-sectional study was conducted on 10,663 individuals aged 40–70 years old, using the baseline data of Kharamah cohort study, which started in 2014. Among all participants, 2251 individuals had a history of kidney stone. The participants’ demographic characteristics, behavioral habits, and the history of underlying diseases were investigated. The crude and Age Standardized Prevalence Rate of kidney stones was calculated. Also, logistic regression was used to identify the predictors of kidney stone. To check the goodness of fit index of the model, we used the Hosmer–Lemeshow test. All analyses were performed in STATA software. Results The prevalence of kidney stone was estimated 21.11%. Also, the Age Standardized Prevalence Rate in men and women was calculated 24.3% and 18.7%, respectively. The mean age of the participants was 52.15 years. Higher prevalence of kidney stone was seen in women aged 40–50 years (40.47%, p = 0.0001) and moderate level of social economic status (31.47%, p = 0.03), men with overweight (44.69%, p < 0.0001) and those in a very high level of social economic status (35.75%, p = 0.001). The results of multiple logistic regression showed that the chance of having kidney stone was 1.17 times higher in diabetic individuals, 1.43 times higher in hypertensive individuals, 2.21 times higher in individuals with fatty liver, and 1.35 times higher in individuals with overweight. The level of socio economic status, male sex, and age were the other factors related to kidney stone. Conclusion In this study, underlying diseases such as fatty liver, diabetes, and hypertension as well as age, male sex, overweight, and high social economic status were identified as important risk factors for kidney stone. Therefore, identifying individuals at risk of kidney stone and providing the necessary training can greatly help to reduce this disease. However, health policymakers should prepare preventive strategies to reduce the occurrence of kidney stone. Abstract Background Kidney stone is the major cause of morbidity, and its prevalence is increasing in the world. This study aimed to assess the prevalence and risk factors of kidney stone in the adult population of southern Iran based on the data of the Kharameh Cohort Study. Methods This cross-sectional study was conducted on 10,663 individuals aged 40–70 years old, using the baseline data of Kharamah cohort study, which started in 2014. Among all participants, 2251 individuals had a history of kidney stone. The participants’ demographic characteristics, behavioral habits, and the history of underlying diseases were investigated. The crude and Age Standardized Prevalence Rate of kidney stones was calculated. Also, logistic regression was used to identify the predictors of kidney stone. To check the goodness of fit index of the model, we used the Hosmer–Lemeshow test. All analyses were performed in STATA software. Results The prevalence of kidney stone was estimated 21.11%. Also, the Age Standardized Prevalence Rate in men and women was calculated 24.3% and 18.7%, respectively. The mean age of the participants was 52.15 years. Higher prevalence of kidney stone was seen in women aged 40–50 years (40.47%, p = 0.0001) and moderate level of social economic status (31.47%, p = 0.03), men with overweight (44.69%, p < 0.0001) and those in a very high level of social economic status (35.75%, p = 0.001). The results of multiple logistic regression showed that the chance of having kidney stone was 1.17 times higher in diabetic individuals, 1.43 times higher in hypertensive individuals, 2.21 times higher in individuals with fatty liver, and 1.35 times higher in individuals with overweight. The level of socio economic status, male sex, and age were the other factors related to kidney stone. Conclusion In this study, underlying diseases such as fatty liver, diabetes, and hypertension as well as age, male sex, overweight, and high social economic status were identified as important risk factors for kidney stone. Therefore, identifying individuals at risk of kidney stone and providing the necessary training can greatly help to reduce this disease. However, health policymakers should prepare preventive strategies to reduce the occurrence of kidney stone. Background Kidney stone is the major cause of morbidity, and its prevalence is increasing in the world. This study aimed to assess the prevalence and risk factors of kidney stone in the adult population of southern Iran based on the data of the Kharameh Cohort Study. Methods This cross-sectional study was conducted on 10,663 individuals aged 40-70 years old, using the baseline data of Kharamah cohort study, which started in 2014. Among all participants, 2251 individuals had a history of kidney stone. The participants' demographic characteristics, behavioral habits, and the history of underlying diseases were investigated. The crude and Age Standardized Prevalence Rate of kidney stones was calculated. Also, logistic regression was used to identify the predictors of kidney stone. To check the goodness of fit index of the model, we used the Hosmer-Lemeshow test. All analyses were performed in STATA software. Results The prevalence of kidney stone was estimated 21.11%. Also, the Age Standardized Prevalence Rate in men and women was calculated 24.3% and 18.7%, respectively. The mean age of the participants was 52.15 years. Higher prevalence of kidney stone was seen in women aged 40-50 years (40.47%, p = 0.0001) and moderate level of social economic status (31.47%, p = 0.03), men with overweight (44.69%, p < 0.0001) and those in a very high level of social economic status (35.75%, p = 0.001). The results of multiple logistic regression showed that the chance of having kidney stone was 1.17 times higher in diabetic individuals, 1.43 times higher in hypertensive individuals, 2.21 times higher in individuals with fatty liver, and 1.35 times higher in individuals with overweight. The level of socio economic status, male sex, and age were the other factors related to kidney stone. Conclusion In this study, underlying diseases such as fatty liver, diabetes, and hypertension as well as age, male sex, overweight, and high social economic status were identified as important risk factors for kidney stone. Therefore, identifying individuals at risk of kidney stone and providing the necessary training can greatly help to reduce this disease. However, health policymakers should prepare preventive strategies to reduce the occurrence of kidney stone. Keywords: Prevalence, Risk factor, Kidney stone, PERSIAN cohort Kidney stone is the major cause of morbidity, and its prevalence is increasing in the world. This study aimed to assess the prevalence and risk factors of kidney stone in the adult population of southern Iran based on the data of the Kharameh Cohort Study. This cross-sectional study was conducted on 10,663 individuals aged 40-70 years old, using the baseline data of Kharamah cohort study, which started in 2014. Among all participants, 2251 individuals had a history of kidney stone. The participants' demographic characteristics, behavioral habits, and the history of underlying diseases were investigated. The crude and Age Standardized Prevalence Rate of kidney stones was calculated. Also, logistic regression was used to identify the predictors of kidney stone. To check the goodness of fit index of the model, we used the Hosmer-Lemeshow test. All analyses were performed in STATA software. The prevalence of kidney stone was estimated 21.11%. Also, the Age Standardized Prevalence Rate in men and women was calculated 24.3% and 18.7%, respectively. The mean age of the participants was 52.15 years. Higher prevalence of kidney stone was seen in women aged 40-50 years (40.47%, p = 0.0001) and moderate level of social economic status (31.47%, p = 0.03), men with overweight (44.69%, p < 0.0001) and those in a very high level of social economic status (35.75%, p = 0.001). The results of multiple logistic regression showed that the chance of having kidney stone was 1.17 times higher in diabetic individuals, 1.43 times higher in hypertensive individuals, 2.21 times higher in individuals with fatty liver, and 1.35 times higher in individuals with overweight. The level of socio economic status, male sex, and age were the other factors related to kidney stone. In this study, underlying diseases such as fatty liver, diabetes, and hypertension as well as age, male sex, overweight, and high social economic status were identified as important risk factors for kidney stone. Therefore, identifying individuals at risk of kidney stone and providing the necessary training can greatly help to reduce this disease. However, health policymakers should prepare preventive strategies to reduce the occurrence of kidney stone. Background Kidney stone is the major cause of morbidity, and its prevalence is increasing in the world. This study aimed to assess the prevalence and risk factors of kidney stone in the adult population of southern Iran based on the data of the Kharameh Cohort Study. Methods This cross-sectional study was conducted on 10,663 individuals aged 40–70 years old, using the baseline data of Kharamah cohort study, which started in 2014. Among all participants, 2251 individuals had a history of kidney stone. The participants’ demographic characteristics, behavioral habits, and the history of underlying diseases were investigated. The crude and Age Standardized Prevalence Rate of kidney stones was calculated. Also, logistic regression was used to identify the predictors of kidney stone. To check the goodness of fit index of the model, we used the Hosmer–Lemeshow test. All analyses were performed in STATA software. Results The prevalence of kidney stone was estimated 21.11%. Also, the Age Standardized Prevalence Rate in men and women was calculated 24.3% and 18.7%, respectively. The mean age of the participants was 52.15 years. Higher prevalence of kidney stone was seen in women aged 40–50 years (40.47%, p = 0.0001) and moderate level of social economic status (31.47%, p = 0.03), men with overweight (44.69%, p < 0.0001) and those in a very high level of social economic status (35.75%, p = 0.001). The results of multiple logistic regression showed that the chance of having kidney stone was 1.17 times higher in diabetic individuals, 1.43 times higher in hypertensive individuals, 2.21 times higher in individuals with fatty liver, and 1.35 times higher in individuals with overweight. The level of socio economic status, male sex, and age were the other factors related to kidney stone. Conclusion In this study, underlying diseases such as fatty liver, diabetes, and hypertension as well as age, male sex, overweight, and high social economic status were identified as important risk factors for kidney stone. Therefore, identifying individuals at risk of kidney stone and providing the necessary training can greatly help to reduce this disease. However, health policymakers should prepare preventive strategies to reduce the occurrence of kidney stone. Kidney stone is the major cause of morbidity, and its prevalence is increasing in the world. This study aimed to assess the prevalence and risk factors of kidney stone in the adult population of southern Iran based on the data of the Kharameh Cohort Study.BACKGROUNDKidney stone is the major cause of morbidity, and its prevalence is increasing in the world. This study aimed to assess the prevalence and risk factors of kidney stone in the adult population of southern Iran based on the data of the Kharameh Cohort Study.This cross-sectional study was conducted on 10,663 individuals aged 40-70 years old, using the baseline data of Kharamah cohort study, which started in 2014. Among all participants, 2251 individuals had a history of kidney stone. The participants' demographic characteristics, behavioral habits, and the history of underlying diseases were investigated. The crude and Age Standardized Prevalence Rate of kidney stones was calculated. Also, logistic regression was used to identify the predictors of kidney stone. To check the goodness of fit index of the model, we used the Hosmer-Lemeshow test. All analyses were performed in STATA software.METHODSThis cross-sectional study was conducted on 10,663 individuals aged 40-70 years old, using the baseline data of Kharamah cohort study, which started in 2014. Among all participants, 2251 individuals had a history of kidney stone. The participants' demographic characteristics, behavioral habits, and the history of underlying diseases were investigated. The crude and Age Standardized Prevalence Rate of kidney stones was calculated. Also, logistic regression was used to identify the predictors of kidney stone. To check the goodness of fit index of the model, we used the Hosmer-Lemeshow test. All analyses were performed in STATA software.The prevalence of kidney stone was estimated 21.11%. Also, the Age Standardized Prevalence Rate in men and women was calculated 24.3% and 18.7%, respectively. The mean age of the participants was 52.15 years. Higher prevalence of kidney stone was seen in women aged 40-50 years (40.47%, p = 0.0001) and moderate level of social economic status (31.47%, p = 0.03), men with overweight (44.69%, p < 0.0001) and those in a very high level of social economic status (35.75%, p = 0.001). The results of multiple logistic regression showed that the chance of having kidney stone was 1.17 times higher in diabetic individuals, 1.43 times higher in hypertensive individuals, 2.21 times higher in individuals with fatty liver, and 1.35 times higher in individuals with overweight. The level of socio economic status, male sex, and age were the other factors related to kidney stone.RESULTSThe prevalence of kidney stone was estimated 21.11%. Also, the Age Standardized Prevalence Rate in men and women was calculated 24.3% and 18.7%, respectively. The mean age of the participants was 52.15 years. Higher prevalence of kidney stone was seen in women aged 40-50 years (40.47%, p = 0.0001) and moderate level of social economic status (31.47%, p = 0.03), men with overweight (44.69%, p < 0.0001) and those in a very high level of social economic status (35.75%, p = 0.001). The results of multiple logistic regression showed that the chance of having kidney stone was 1.17 times higher in diabetic individuals, 1.43 times higher in hypertensive individuals, 2.21 times higher in individuals with fatty liver, and 1.35 times higher in individuals with overweight. The level of socio economic status, male sex, and age were the other factors related to kidney stone.In this study, underlying diseases such as fatty liver, diabetes, and hypertension as well as age, male sex, overweight, and high social economic status were identified as important risk factors for kidney stone. Therefore, identifying individuals at risk of kidney stone and providing the necessary training can greatly help to reduce this disease. However, health policymakers should prepare preventive strategies to reduce the occurrence of kidney stone.CONCLUSIONIn this study, underlying diseases such as fatty liver, diabetes, and hypertension as well as age, male sex, overweight, and high social economic status were identified as important risk factors for kidney stone. Therefore, identifying individuals at risk of kidney stone and providing the necessary training can greatly help to reduce this disease. However, health policymakers should prepare preventive strategies to reduce the occurrence of kidney stone. Kidney stone is the major cause of morbidity, and its prevalence is increasing in the world. This study aimed to assess the prevalence and risk factors of kidney stone in the adult population of southern Iran based on the data of the Kharameh Cohort Study. This cross-sectional study was conducted on 10,663 individuals aged 40-70 years old, using the baseline data of Kharamah cohort study, which started in 2014. Among all participants, 2251 individuals had a history of kidney stone. The participants' demographic characteristics, behavioral habits, and the history of underlying diseases were investigated. The crude and Age Standardized Prevalence Rate of kidney stones was calculated. Also, logistic regression was used to identify the predictors of kidney stone. To check the goodness of fit index of the model, we used the Hosmer-Lemeshow test. All analyses were performed in STATA software. The prevalence of kidney stone was estimated 21.11%. Also, the Age Standardized Prevalence Rate in men and women was calculated 24.3% and 18.7%, respectively. The mean age of the participants was 52.15 years. Higher prevalence of kidney stone was seen in women aged 40-50 years (40.47%, p = 0.0001) and moderate level of social economic status (31.47%, p = 0.03), men with overweight (44.69%, p < 0.0001) and those in a very high level of social economic status (35.75%, p = 0.001). The results of multiple logistic regression showed that the chance of having kidney stone was 1.17 times higher in diabetic individuals, 1.43 times higher in hypertensive individuals, 2.21 times higher in individuals with fatty liver, and 1.35 times higher in individuals with overweight. The level of socio economic status, male sex, and age were the other factors related to kidney stone. In this study, underlying diseases such as fatty liver, diabetes, and hypertension as well as age, male sex, overweight, and high social economic status were identified as important risk factors for kidney stone. Therefore, identifying individuals at risk of kidney stone and providing the necessary training can greatly help to reduce this disease. However, health policymakers should prepare preventive strategies to reduce the occurrence of kidney stone. |
ArticleNumber | 205 |
Audience | Academic |
Author | Jafari, Fatemeh Rezaianzadeh, Abbas Hosseini, Seyed Vahid Ghoddusi Johari, Masoumeh Rezaeianzadeh, Ramin Moftakhar, Leila |
Author_xml | – sequence: 1 givenname: Leila surname: Moftakhar fullname: Moftakhar, Leila organization: Student Research Committee, Shiraz University of Medical Sciences – sequence: 2 givenname: Fatemeh surname: Jafari fullname: Jafari, Fatemeh organization: Student Research Committee, Shiraz University of Medical Sciences – sequence: 3 givenname: Masoumeh surname: Ghoddusi Johari fullname: Ghoddusi Johari, Masoumeh email: m.ghoddusi94@yahoo.com organization: Breast Diseases Research Center, Shiraz University of Medical Sciences – sequence: 4 givenname: Ramin surname: Rezaeianzadeh fullname: Rezaeianzadeh, Ramin organization: Experimental Medicine Program, Department of Medicine, Faculty of Medicine, University of British Columbia – sequence: 5 givenname: Seyed Vahid surname: Hosseini fullname: Hosseini, Seyed Vahid organization: Colorectal Research Center, Shiraz University of Medical Sciences – sequence: 6 givenname: Abbas surname: Rezaianzadeh fullname: Rezaianzadeh, Abbas organization: Colorectal Research Center, Shiraz University of Medical Sciences |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36536352$$D View this record in MEDLINE/PubMed |
BookMark | eNp9ks1u1DAUhSNURH_gBVggS2y6SbETx7FZIFUVPyMqwQLWlmPfzHiasQc7qTo73oHX4Kl4EpxJS2cqVHlhyz7nu_K95zg7cN5Blr0k-IwQzt5EUnBBc1wUOSaEkfzmSXZEaE3yggp8sHM-zI5jXGJMal6xZ9lhyaqSlVVxlP3-GuBadeA0IOUMCjZeoVbp3oeIfIuurHGwQbFPpZGxEVQEZB1a-_XQqd56h9QcDKL4z89fNUYbUKOxM6Po80IFtYIF0n7hQ58og9m8RQrp4GPMI-gRoLodWt6kAmZSjojoh34BwaFZUO559rRVXYQXt_tJ9v3D-28Xn_LLLx9nF-eXuWa47nPBGw214jVpcdNgVRpoK1ZVRojUkVILUomCGq6N0KknhhqhQBBjOCHpqMuTbDZxjVdLuQ52pcJGemXl9sKHuVSht7oDWakCSKWhKUpMGVBOBGWEk0aUhjFWJ9a7ibUemhUYDa4PqtuD7r84u5Bzfy1FzSitcQKc3gKC_zFA7OXKRg1dpxz4IcqirhgpSlLxJH39QLr0Q0gN3qoqjjmp6b1qnuYurWt9qqtHqDyvS8y4EIIl1dl_VGkZWFmd0tDadL9neLX70X8_vMtaEvBJsJ1-gFZq22-Hnsi2kwTLMdZyirVMsZbbWMubZC0eWO_oj5rKyRST2M0h3HfjEddf8OoMow |
CitedBy_id | crossref_primary_10_1007_s10439_024_03610_0 crossref_primary_10_3389_fmolb_2024_1494779 crossref_primary_10_4103_bhsj_bhsj_30_24 crossref_primary_10_1007_s11255_024_04112_7 crossref_primary_10_1038_s41598_024_60227_y crossref_primary_10_1097_MNH_0000000000001062 crossref_primary_10_1080_20905998_2023_2254960 crossref_primary_10_3390_jcm13196017 crossref_primary_10_4103_ua_ua_111_23 crossref_primary_10_3390_healthcare11030424 crossref_primary_10_7759_cureus_70136 crossref_primary_10_34133_jbioxresearch_0022 crossref_primary_10_3390_jcm12123879 crossref_primary_10_1186_s12882_025_04018_1 crossref_primary_10_1080_21688370_2023_2210051 crossref_primary_10_1097_JU9_0000000000000107 crossref_primary_10_1159_000543404 crossref_primary_10_1007_s00345_024_04919_0 crossref_primary_10_1186_s12944_024_02150_9 crossref_primary_10_1007_s13410_023_01273_6 crossref_primary_10_3390_cryst14100854 crossref_primary_10_7759_cureus_77465 crossref_primary_10_5897_JMPR2023_7296 crossref_primary_10_1002_hsr2_1264 crossref_primary_10_1186_s41182_023_00527_7 crossref_primary_10_3390_medicina60101630 crossref_primary_10_4103_ua_ua_1_24 crossref_primary_10_22207_JPAM_18_4_44 crossref_primary_10_4236_ojneph_2024_144045 crossref_primary_10_1007_s11739_024_03705_5 crossref_primary_10_22141_2307_1257_13_2_2024_454 |
Cites_doi | 10.1046/j.1523-1755.2003.00917.x 10.1016/j.juro.2011.07.011 10.1016/j.annepidem.2009.02.006 10.1007/s11255-018-1849-2 10.5812/numonthly.5251 10.1016/j.ucl.2007.04.003 10.3923/ajdd.2017.54.62 10.1016/j.eururo.2013.03.026 10.1159/000076588 10.1111/bju.13828 10.1155/2018/3068365 10.1016/j.clinimag.2017.03.011 10.1016/j.euf.2020.08.011 10.4149/endo_2013_01_27 10.1038/ki.2012.320 10.1016/S0302-2838(03)00415-9 10.1186/s12894-021-00905-5 10.1371/journal.pone.0184506 10.4111/icu.2018.59.3.158 10.1111/j.1442-2042.1996.tb00511.x 10.1038/s41598-016-0028-x 10.1080/00365590600589898 10.1016/j.urology.2007.09.034 10.1056/NEJMra0912063 10.1007/s10654-014-9904-5 10.1016/j.urology.2011.04.011 10.18502/acta.v58i10.4911 10.1016/j.eururo.2014.06.036 10.1126/science.3287615 10.1186/s12894-018-0428-2 10.1016/j.puhe.2016.02.028 10.1016/j.juro.2014.09.010 10.1186/s12894-018-0331-x 10.1016/j.eururo.2012.03.052 10.1007/s00240-007-0084-6 10.1186/s12882-015-0126-1 10.4103/1319-2442.152557 10.1007/s11255-009-9588-z 10.5489/cuaj.2879 10.1016/j.euf.2019.05.002 10.1007/s10654-018-0426-4 10.1159/000048445 10.2215/CJN.03210312 10.1007/s00240-009-0221-5 10.1007/s00240-010-0346-6 10.1016/j.juro.2012.08.247 10.1681/ASN.2010030253 10.1001/jama.293.4.455 10.2169/internalmedicine.51.6426 10.1016/S0140-6736(01)05782-8 10.1038/s41416-018-0356-7 10.1038/nrneph.2009.114 10.3109/0886022X.2012.713298 10.1016/j.urology.2009.09.024 |
ContentType | Journal Article |
Copyright | The Author(s) 2022 2022. The Author(s). COPYRIGHT 2022 BioMed Central Ltd. 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2022 – notice: 2022. The Author(s). – notice: COPYRIGHT 2022 BioMed Central Ltd. – notice: 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QP 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM DOA |
DOI | 10.1186/s12894-022-01161-x |
DatabaseName | SpringerOpen Free (Free internet resource, activated by CARLI) CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) 开放获取期刊(Open Access Journals) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1471-2490 |
EndPage | 9 |
ExternalDocumentID | oai_doaj_org_article_5a2e15ceb23046e481946181b93d6667 PMC9764470 A730689996 36536352 10_1186_s12894_022_01161_x |
Genre | Journal Article |
GeographicLocations | Iran |
GeographicLocations_xml | – name: Iran |
GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABUWG ACGFO ACGFS ACIHN ACPRK ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EBD EBLON EBS EMB EMOBN F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 UKHRP W2D WOQ WOW XSB AAYXX ALIPV CITATION -A0 3V. ACRMQ ADINQ C24 CGR CUY CVF ECM EIF NPM PMFND 7QP 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI 7X8 5PM |
ID | FETCH-LOGICAL-c607t-98bce7a871f0bb0a3def5655d991473c915924d8cd9c001d4d9ae91dd811d9ac3 |
IEDL.DBID | M48 |
ISSN | 1471-2490 |
IngestDate | Wed Aug 27 01:28:19 EDT 2025 Thu Aug 21 18:38:53 EDT 2025 Fri Sep 05 07:13:44 EDT 2025 Fri Jul 25 21:11:12 EDT 2025 Tue Jun 17 21:31:56 EDT 2025 Tue Jun 10 20:53:37 EDT 2025 Thu Jan 02 22:54:58 EST 2025 Tue Jul 01 01:02:47 EDT 2025 Thu Apr 24 23:07:03 EDT 2025 Sat Sep 06 07:22:58 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Prevalence PERSIAN cohort Kidney stone Risk factor |
Language | English |
License | 2022. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c607t-98bce7a871f0bb0a3def5655d991473c915924d8cd9c001d4d9ae91dd811d9ac3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12894-022-01161-x |
PMID | 36536352 |
PQID | 2755808174 |
PQPubID | 42551 |
PageCount | 9 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_5a2e15ceb23046e481946181b93d6667 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9764470 proquest_miscellaneous_2756123158 proquest_journals_2755808174 gale_infotracmisc_A730689996 gale_infotracacademiconefile_A730689996 pubmed_primary_36536352 crossref_citationtrail_10_1186_s12894_022_01161_x crossref_primary_10_1186_s12894_022_01161_x springer_journals_10_1186_s12894_022_01161_x |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-12-19 |
PublicationDateYYYYMMDD | 2022-12-19 |
PublicationDate_xml | – month: 12 year: 2022 text: 2022-12-19 day: 19 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | BMC urology |
PublicationTitleAbbrev | BMC Urol |
PublicationTitleAlternate | BMC Urol |
PublicationYear | 2022 |
Publisher | BioMed Central BioMed Central Ltd BMC |
Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: BMC |
References | ZM El-Zoghby (1161_CR12) 2012; 7 G Bihl (1161_CR25) 2001; 358 F Shirazi (1161_CR29) 2009; 11 A Khan (1161_CR32) 2018; 50 PM Ferraro (1161_CR64) 2015; 193 VO Edvardsson (1161_CR18) 2013; 83 AY Muslumanoglu (1161_CR43) 2011; 39 W Wang (1161_CR22) 2017; 7 P Khalili (1161_CR28) 2021; 21 1161_CR14 Y-H Lee (1161_CR41) 2002; 68 A-R Zeina (1161_CR54) 2017; 43 D Aune (1161_CR3) 2018; 33 M Inci (1161_CR36) 2012; 34 S Nikpay (1161_CR2) 2016; 4 A Hesse (1161_CR26) 2003; 44 S Kim (1161_CR49) 2017; 12 M Słojewski (1161_CR59) 2009; 37 VK Sigurjonsdottir (1161_CR11) 2015; 16 G Targher (1161_CR52) 2010; 363 M Moniruzzaman (1161_CR19) 2016; 137 MR Safarinejad (1161_CR30) 2007; 35 EN Taylor (1161_CR38) 2005; 293 T Yasui (1161_CR42) 2008; 71 JA van de Pol (1161_CR7) 2019; 120 V Agrawal (1161_CR50) 2009; 5 A Basiri (1161_CR56) 2010; 42 A Sohgaura (1161_CR45) 2017; 7 HN Sofia (1161_CR63) 2016; 5 V Romero (1161_CR1) 2010; 12 CD Scales Jr (1161_CR9) 2012; 62 S Shahidi (1161_CR39) 2022; 60 A Memon (1161_CR44) 2012 P Jones (1161_CR16) 2021; 35 BH Eisner (1161_CR40) 2010; 75 M Soueidan (1161_CR61) 2015; 9 G Zeng (1161_CR23) 2017; 120 T Meschi (1161_CR65) 2004; 72 JA Antonelli (1161_CR17) 2014; 66 B Einollahi (1161_CR51) 2013; 47 P Mitra (1161_CR55) 2018; 59 1161_CR31 S-D Chung (1161_CR46) 2011; 186 F Ahmad (1161_CR24) 2015; 26 BW Turney (1161_CR8) 2014; 29 M Iguchi (1161_CR34) 1996; 3 S Farshid (1161_CR5) 2020 JA Swets (1161_CR20) 1988; 240 S Nowfar (1161_CR37) 2011; 78 Y Kabeya (1161_CR48) 2012; 51 M Abufaraj (1161_CR57) 2021; 7 MR Tamadon (1161_CR62) 2013; 5 AE Weinberg (1161_CR47) 2014; 65 R-h Ma (1161_CR4) 2018; 18 SS Kale (1161_CR33) 2014; 24 KK Stamatelou (1161_CR21) 2003; 63 AD Rule (1161_CR13) 2010; 21 GC Curhan (1161_CR35) 2007; 34 F Tadayyon (1161_CR6) 2011; 28 Y-p Wei (1161_CR53) 2018; 12 CC Liu (1161_CR60) 2009; 19 TJ Littlejohns (1161_CR10) 2020; 6 OS Indridason (1161_CR27) 2006; 40 A Okada (1161_CR58) 2018; 18 KL Penniston (1161_CR15) 2013; 189 |
References_xml | – volume: 63 start-page: 1817 issue: 5 year: 2003 ident: 1161_CR21 publication-title: Kidney Int doi: 10.1046/j.1523-1755.2003.00917.x – volume: 186 start-page: 1888 issue: 5 year: 2011 ident: 1161_CR46 publication-title: J Urol doi: 10.1016/j.juro.2011.07.011 – volume: 19 start-page: 539 issue: 8 year: 2009 ident: 1161_CR60 publication-title: Ann Epidemiol doi: 10.1016/j.annepidem.2009.02.006 – volume: 50 start-page: 799 issue: 5 year: 2018 ident: 1161_CR32 publication-title: Int Urol Nephrol doi: 10.1007/s11255-018-1849-2 – start-page: 21 volume-title: Epidemiology of stone disease in Pakistan year: 2012 ident: 1161_CR44 – volume: 5 start-page: 702 issue: 1 year: 2013 ident: 1161_CR62 publication-title: Nephro-Urol Month doi: 10.5812/numonthly.5251 – volume: 34 start-page: 287 issue: 3 year: 2007 ident: 1161_CR35 publication-title: Urol Clin North Am doi: 10.1016/j.ucl.2007.04.003 – volume: 7 start-page: 54 issue: 2 year: 2017 ident: 1161_CR45 publication-title: Am J Drug Discov Dev doi: 10.3923/ajdd.2017.54.62 – volume: 11 start-page: 14 issue: 1 year: 2009 ident: 1161_CR29 publication-title: hkjn – volume: 65 start-page: 242 issue: 1 year: 2014 ident: 1161_CR47 publication-title: Eur Urol doi: 10.1016/j.eururo.2013.03.026 – volume: 72 start-page: 29 issue: Suppl 1 year: 2004 ident: 1161_CR65 publication-title: Urol Int doi: 10.1159/000076588 – volume: 120 start-page: 109 issue: 1 year: 2017 ident: 1161_CR23 publication-title: BJUI Compass doi: 10.1111/bju.13828 – ident: 1161_CR14 doi: 10.1155/2018/3068365 – volume: 43 start-page: 148 year: 2017 ident: 1161_CR54 publication-title: Clin Imaging doi: 10.1016/j.clinimag.2017.03.011 – volume: 7 start-page: 1468 issue: 6 year: 2021 ident: 1161_CR57 publication-title: Eur Urol Focus doi: 10.1016/j.euf.2020.08.011 – volume: 47 start-page: 27 issue: 1 year: 2013 ident: 1161_CR51 publication-title: Endocr Regul doi: 10.4149/endo_2013_01_27 – volume: 35 start-page: 1 issue: 1 year: 2021 ident: 1161_CR16 publication-title: Scand J Urol – volume: 83 start-page: 146 issue: 1 year: 2013 ident: 1161_CR18 publication-title: Kidney Int doi: 10.1038/ki.2012.320 – volume: 44 start-page: 709 issue: 6 year: 2003 ident: 1161_CR26 publication-title: Eur Urol doi: 10.1016/S0302-2838(03)00415-9 – volume: 21 start-page: 1 issue: 1 year: 2021 ident: 1161_CR28 publication-title: BMC Urol doi: 10.1186/s12894-021-00905-5 – volume: 12 start-page: e0184506 issue: 10 year: 2017 ident: 1161_CR49 publication-title: PLoS ONE doi: 10.1371/journal.pone.0184506 – volume: 59 start-page: 158 issue: 3 year: 2018 ident: 1161_CR55 publication-title: India Investig Clin Urol doi: 10.4111/icu.2018.59.3.158 – volume: 3 start-page: 175 issue: 3 year: 1996 ident: 1161_CR34 publication-title: Int J Urol doi: 10.1111/j.1442-2042.1996.tb00511.x – volume: 7 start-page: 1 issue: 1 year: 2017 ident: 1161_CR22 publication-title: Sci Rep doi: 10.1038/s41598-016-0028-x – volume: 40 start-page: 215 issue: 3 year: 2006 ident: 1161_CR27 publication-title: Scand J Urol doi: 10.1080/00365590600589898 – volume: 12 start-page: e86 issue: 2–3 year: 2010 ident: 1161_CR1 publication-title: Rev Urol – volume: 28 start-page: 122 year: 2011 ident: 1161_CR6 publication-title: J Isfahan Med Sch – volume: 71 start-page: 209 issue: 2 year: 2008 ident: 1161_CR42 publication-title: Urol doi: 10.1016/j.urology.2007.09.034 – volume: 363 start-page: 1341 issue: 14 year: 2010 ident: 1161_CR52 publication-title: N Engl J Med Overseas Ed doi: 10.1056/NEJMra0912063 – volume: 29 start-page: 363 issue: 5 year: 2014 ident: 1161_CR8 publication-title: Eur J Epidemiol doi: 10.1007/s10654-014-9904-5 – volume: 78 start-page: 1029 issue: 5 year: 2011 ident: 1161_CR37 publication-title: Urol doi: 10.1016/j.urology.2011.04.011 – year: 2020 ident: 1161_CR5 publication-title: Acta Med Iran doi: 10.18502/acta.v58i10.4911 – volume: 66 start-page: 724 issue: 4 year: 2014 ident: 1161_CR17 publication-title: Eur Urol doi: 10.1016/j.eururo.2014.06.036 – volume: 240 start-page: 1285 issue: 4857 year: 1988 ident: 1161_CR20 publication-title: Sci doi: 10.1126/science.3287615 – volume: 5 start-page: 183 year: 2016 ident: 1161_CR63 publication-title: Glob J Res Anal. – volume: 18 start-page: 1 issue: 1 year: 2018 ident: 1161_CR4 publication-title: BMC Urol doi: 10.1186/s12894-018-0428-2 – volume: 137 start-page: 131 year: 2016 ident: 1161_CR19 publication-title: Public Health doi: 10.1016/j.puhe.2016.02.028 – volume: 193 start-page: 864 issue: 3 year: 2015 ident: 1161_CR64 publication-title: J Urol doi: 10.1016/j.juro.2014.09.010 – volume: 24 start-page: 278 issue: 3 year: 2014 ident: 1161_CR33 publication-title: IJEHR – volume: 18 start-page: 1 issue: 1 year: 2018 ident: 1161_CR58 publication-title: BMC Urol doi: 10.1186/s12894-018-0331-x – volume: 62 start-page: 160 issue: 1 year: 2012 ident: 1161_CR9 publication-title: Eur Urol doi: 10.1016/j.eururo.2012.03.052 – volume: 35 start-page: 73 issue: 2 year: 2007 ident: 1161_CR30 publication-title: Urol Res doi: 10.1007/s00240-007-0084-6 – volume: 16 start-page: 1 issue: 1 year: 2015 ident: 1161_CR11 publication-title: BMC nephrol doi: 10.1186/s12882-015-0126-1 – volume: 26 start-page: 386 issue: 2 year: 2015 ident: 1161_CR24 publication-title: Saudi J Kidney Dis Transpl doi: 10.4103/1319-2442.152557 – volume: 42 start-page: 119 issue: 1 year: 2010 ident: 1161_CR56 publication-title: Int Urol Nephrol doi: 10.1007/s11255-009-9588-z – volume: 9 start-page: 257 issue: 7–8 year: 2015 ident: 1161_CR61 publication-title: Can Urol Assoc J doi: 10.5489/cuaj.2879 – volume: 6 start-page: 752 issue: 4 year: 2020 ident: 1161_CR10 publication-title: Eur Urol Focus doi: 10.1016/j.euf.2019.05.002 – volume: 33 start-page: 1033 issue: 11 year: 2018 ident: 1161_CR3 publication-title: Eur J Epidemiol doi: 10.1007/s10654-018-0426-4 – volume: 68 start-page: 172 issue: 3 year: 2002 ident: 1161_CR41 publication-title: Urol Int doi: 10.1159/000048445 – volume: 7 start-page: 1409 issue: 9 year: 2012 ident: 1161_CR12 publication-title: Clin J Am Soc Nephrol doi: 10.2215/CJN.03210312 – volume: 37 start-page: 317 issue: 6 year: 2009 ident: 1161_CR59 publication-title: Urol Res doi: 10.1007/s00240-009-0221-5 – ident: 1161_CR31 – volume: 39 start-page: 309 issue: 4 year: 2011 ident: 1161_CR43 publication-title: Urol Res doi: 10.1007/s00240-010-0346-6 – volume: 4 start-page: 102 issue: 3 year: 2016 ident: 1161_CR2 publication-title: West of Iran j ped nephrol – volume: 189 start-page: 921 issue: 3 year: 2013 ident: 1161_CR15 publication-title: J Urol doi: 10.1016/j.juro.2012.08.247 – volume: 21 start-page: 1641 issue: 10 year: 2010 ident: 1161_CR13 publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2010030253 – volume: 293 start-page: 455 issue: 4 year: 2005 ident: 1161_CR38 publication-title: JAMA doi: 10.1001/jama.293.4.455 – volume: 60 start-page: 307 issue: 5 year: 2022 ident: 1161_CR39 publication-title: Acta Med Iran – volume: 51 start-page: 699 issue: 7 year: 2012 ident: 1161_CR48 publication-title: Intern Med doi: 10.2169/internalmedicine.51.6426 – volume: 358 start-page: 651 issue: 9282 year: 2001 ident: 1161_CR25 publication-title: The Lancet doi: 10.1016/S0140-6736(01)05782-8 – volume: 120 start-page: 368 issue: 3 year: 2019 ident: 1161_CR7 publication-title: Br J Cancer doi: 10.1038/s41416-018-0356-7 – volume: 5 start-page: 520 issue: 9 year: 2009 ident: 1161_CR50 publication-title: Nat Rev Nephrol doi: 10.1038/nrneph.2009.114 – volume: 12 start-page: 112 issue: 2 year: 2018 ident: 1161_CR53 publication-title: Iran J Kidney Dis – volume: 34 start-page: 1140 issue: 9 year: 2012 ident: 1161_CR36 publication-title: Ren Fail doi: 10.3109/0886022X.2012.713298 – volume: 75 start-page: 1289 issue: 6 year: 2010 ident: 1161_CR40 publication-title: Urol doi: 10.1016/j.urology.2009.09.024 |
SSID | ssj0017856 |
Score | 2.4476125 |
Snippet | Background
Kidney stone is the major cause of morbidity, and its prevalence is increasing in the world. This study aimed to assess the prevalence and risk... Kidney stone is the major cause of morbidity, and its prevalence is increasing in the world. This study aimed to assess the prevalence and risk factors of... Background Kidney stone is the major cause of morbidity, and its prevalence is increasing in the world. This study aimed to assess the prevalence and risk... Abstract Background Kidney stone is the major cause of morbidity, and its prevalence is increasing in the world. This study aimed to assess the prevalence and... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 205 |
SubjectTerms | Accuracy Adult Age Aged Body mass index Body weight Calculi Cohort analysis Cohort Studies Cross-Sectional Studies Diabetes Diabetes mellitus Disease Fatty liver Female Humans Hypertension Internal Medicine Iran - epidemiology Kidney Calculi - epidemiology Kidney stone Kidney stones Kidneys Male Medical research Medicine Medicine & Public Health Medicine, Experimental Metabolism Middle Aged Morbidity Nephrolithiasis Overweight PERSIAN cohort Population Population studies Population-based studies Prevalence Prevalence studies (Epidemiology) Regression analysis Risk factor Risk Factors Urology Womens health |
SummonAdditionalLinks | – databaseName: 开放获取期刊(Open Access Journals) dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LbtUwELVQF4gN4k2gICMhsQCrTvxK2BVEVUBlRaXuLMd21CtKbtV7K7U7_oHf4Kv4EmYcJ22KgA1SFlE8jmzPeB7y-Awhz71S0fhKMCNMx6RoO9YG4ViF5dxV1xqTcLr3PundffnhQB1cKvWFOWEDPPCwcFvKVbFUHgJAPMOLEiyY1GCW2kYEcL3TPXLe8DGYyucHplZ6vCJT660VaGGEwK0wDQF8HHY2M0MJrf93nXzJKF1NmLxyapqM0c4tcjN7kXR7GP1tci32d8j1vXxOfpf8QGQml-4TUdcHignkNJfWocuOflmEPp5TdPwizWc0dNHT46mcFwU9E6jkP799N5yew36AjkcBiT4ixvPXeEixuO7JmiaE2tfU0TRVtkrJXTi8i78xNJZhoMRfrJYpsb6n78FU3iP7O-8-v91luS4D85qbNWvq1kfjINTqeNtyJ0LswC9UAXxNaYRvwEWqJJZFajzwIsiACOBlCHVZwqsX98lGD_N7SKh0uom65kb7IOuOu7KLUnZYDsQZY3xBypFN1mfQcqydcWRT8FJrO7DWAmttYq09K8jLqc_xANnxV-o3yP2JEuG20wcQQpuF0P5LCAvyAmXHolKA4XmX7zbAJBFey26DHtU1xpYF2ZxRwmb28-ZR-mxWJitbGaVwRYwsyLOpGXtiglwfl6eJBoF0SlUX5MEgrNOUhFYC_MqqIGYmxrM5z1v6xWGCGgdnVUrDC_JqFPiLYf15TR_9jzV9TG5UuGFLeJpNsrE-OY1PwAFct0_TXv8FimlXKQ priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NbtQwELagSIgL4p9AQUZC4gBW8-OfhAsqiKqAyolKe7Mc22lXlGTZ3UrtjXfgNXgqnoQZx8mSIirtYbWeRJ4dz_izPf6GkOdWCK9sXjBVqIbxom5Y7QrDciznLppaqcDTffBZ7h_yjzMxixtuq5hWOcTEEKhdZ3GPfCdXQmCVCMXfLL4zrBqFp6uxhMZVci0DJIKlG9RsXHBh4Xk5XJQp5c4KYjES4eaYjABIh51NJqPA2f9vZP5rarqYNnnh7DRMSXu3yM2IJelub_zb5Ipv75DrB_G0_C75hfxMJtwqoqZ1FNPIaSywQ7uGfp271p9ThH-expMaOm_pYizqRSHaOMrT3z9-qpSeg1fAgycOhT4h0_M3f0yxxO5yTQNP7WtqaFCVrUKKF3Zv8zaGU6brJfEVqy6k17f0A0yY98jh3vsv7_ZZrM7ArEzVmlVlbb0ysOBq0rpOTeF8A-hQOECcXBW2AqCUcyyOVFmwheMOecAz58osg6-2uE-2WtDvIaHcyMrLMlXSOl42qckaz3mD5jZKKZuQbDCTtpG6HCtonOiwhCml7k2rwbQ6mFafJeTl-MyiJ-64VPotWn-URNLt8EO3PNLRh7Uwuc-E9TVupEvPAUxxCQiprgoHq0CVkBc4djSGBuieNfGGAyiJJFt6F6KpLHGFmZDtiSS4tJ02D6NPx5Cy0hsHSMizsRmfxDS51nenQQbpdDJRJuRBP1hHlQopCkCXeULUZBhPdJ62tPPjQDgOkJVzlSbk1TDgN936_3_66HItHpMbObpiBp9qm2ytl6f-CQC8df00ePEfs9tQDQ priority: 102 providerName: ProQuest – databaseName: SpringerOpen Free (Free internet resource, activated by CARLI) dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZQkRAXxJvQgoyExAEskviVcCsrqgIqJyr1Zjl-qCtKtupupfbGf-Bv8Kv4Jcw43rQpDwlpD6v1OPJkxuPP6_E3hDx3Ugbtas4015EJ3kXWeW5ZjeXcZey0Tjzde5_U7r74cCAPMk0O3oW5fH5fNer1EuInktfWmEAA6IQBXrwuIfCiN8_UbDwx0I1U60sxf-w3WXgSP__vUfjSMnQ1RfLKOWlafnZuk1sZN9LtwdB3yLXQ3yU39vLJ-D3yA7mYbLpBRG3vKaaM01xMhy4i_TL3fTinCPUCzacydN7T47GAF4XI4qkof377rkt6DjMAOh55FPqIrM5fwyHFcronK5o4ad9QS5OqbJnSuXB4F09juDz6QRIfsVykVPqevofF8T7Z33n3ebbLciUG5lSpV6xtOhe0hc1VLLuutNyHCEhQekCXQnPXAiiqBRZCah3YwguPnN-V901VwVfHH5CNHvR7RKiwqg2qKbVyXjSxtFUMQkQsAGK11q4g1dpMxmWacqyWcWTSdqVRZjCtAdOaZFpzVpCXY5_jgaTjn9Jv0fqjJBJspx_A70yer0baOlTShQ7_NFdBAHASCtBQ13IPOz5dkBfoOwbDAAzP2XybAZREQi2zDZFTNbibLMjWRBKmr5s2r73P5PCxNLWWEt-IFgV5NjZjT0yJ68PiNMkgdU4lm4I8HJx1VIkryQFJ1gXREzee6Dxt6eeHiVwc4KkQuizIq7XDXwzr7-_08f-Jb5KbNU7NCj7tFtlYnZyGJwDuVt3TNKt_AS9uSWA priority: 102 providerName: Springer Nature |
Title | Prevalence and risk factors of kidney stone disease in population aged 40–70 years old in Kharameh cohort study: a cross-sectional population-based study in southern Iran |
URI | https://link.springer.com/article/10.1186/s12894-022-01161-x https://www.ncbi.nlm.nih.gov/pubmed/36536352 https://www.proquest.com/docview/2755808174 https://www.proquest.com/docview/2756123158 https://pubmed.ncbi.nlm.nih.gov/PMC9764470 https://doaj.org/article/5a2e15ceb23046e481946181b93d6667 |
Volume | 22 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3dbtMwFLbGJiFuEP8LjMpISFxAID_-SZAQWqtNA7QJTVSquLEc22EVJR1tJ613vAOvwVPxJJzjJC0Zgyukqmqa48j2Ocf-HB9_h5DHhnMnTZKGMpVlyNKiDAub6jDBdO68LKT0PN2HR-JgyN6O-GiDtOmOmg6cX7q0w3xSw9nk-fnX5Wtw-Ffe4TPxYg5jLBLcJhhkAAgmBEy55feLMJSPrXcVZMZFe3Dm0nKdyclz-P85Uv82VV0Mo7ywl-qnqP0b5HqDLelubQw3yYarbpGrh83u-W3yA_matD9lRHVlKYaV0ybhDp2W9PPYVm5JEQ462uzc0HFFT1dJviiMPpay6Oe37zKiS_ASKDixKPQOmZ-_uBOKKXdnC-p5a19STX1Tw7kP-cLqrZ8W4hRqa0l8xHzqw-0r-gYm0DtkuL_3YXAQNtkaQiMiuQjzrDBOaliAlVFRRDq1rgS0yC0gUCZTkwNwShgmS8oN6MIyi7zgsbVZHMNPk94lmxW0b5tQpkXuRBZJYSzLykjHpWOsxCQhWkppAhK3alKmoTLHjBoT5Zc0mVC1ahWoVnnVqvOAPF2VOa2JPP4p3UftrySRhNv_MZ19Uo1PK64TF3PjCnyxLhwDcMUEIKYiTy2sCmVAnqDtKDReqJ7RzYkHaCSSbqldGF1FhivOgOx0JMHFTfd2a32q9RCVSM6xRyQLyKPVbSyJYXOVm555GaTXiXkWkHu1sa6alAqeAtpMAiI7Ztxpc_dONT7xBOQAYRmTUUCetQa_rtbf-_T-_-jTB-Ragg4bwyffIZuL2Zl7CLBwUfTIFTmSPbLV3zt6fwxXAzHo-VcsPT8KwPdx_-Mv5dFlIw |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELdGJwEviP8EBhgJxANEyx__SZAmtMGmjq4VQpu0N5PYDqsYaWk7sb7xHfgafAY-DJ-EOzdJyRB7m9SHqD5Hvtz57myff0fIU825lTqKfRnLwmdxXvi5iTM_wnLuvMildDjd_YHoHrB3h_xwhfyq78JgWmVtE52hNiONe-TrkeQcq0RI9nr81ceqUXi6WpfQyKrSCmbDQYxVFzt6dv4NlnDTjd23IO9nUbSzvf-m61dVBnwtAjnz0yTXVmawcCiCPA-y2NgCohxuIHJiMtYpOPyIYZGfVINNN8wgnnVoTBKG8KhjeO8lsspwA6VDVre2B-8_NOcYMuGivqqTiPUpeAOE4o0wHQJiLf-05Q5d1YB_fcNfzvFs4uaZ01vnFHeuk2tVNEs3F-p3g6zY8ia53K_O62-Rn4gQlbl7TTQrDcVEdlqV-KGjgn4emtLOKQagllZnRXRY0nFTVoyCvTOUBb-__5ABncMHh47HBol6iDX9xR5RLPI7mVGHlPuKZtSx6k9dkhkOb_k2H522WVDiK6Yjl-Bf0l1w2bfJwYVI7g7plMDfPUJZJlIrkkAKbVhSBFlYWMYKVLhMSqk9EtZiUroCT8caHsfKLaISoRaiVSBa5USrTj3youkzXkCHnEu9hdJvKBH22_0xmnxSlRVRPItsyLXNcStfWAbhHBMQo-VpbGAdKj3yHHVHoXGC4emsumMBTCLMl9oEey4SXON6ZK1FCUZFt5tr7VOVUZuq5RT0yJOmGXtiol5pRyeOBgF9Qp545O5CWRuWYsFjiG8jj8iWGrd4breUwyMHeQ5BM2My8MjLWuGXw_r_N71_PhePyZXufn9P7e0Oeg_I1QinZQi_dI10ZpMT-xDCzVn-qJrTlHy8aDPyBydnlC0 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZQkSouqLxDCxgJiQNYzcOPhFtZWLWUVhyo1Jvl2A5dUbKr3VSiN_4Df4NfxS9hxnm0KQ8JaQ-r9TiyM57x553xN4Q8s0J4ZdOMqUxVjGdlxUqXGZZiOXdRlUoFnu6DQ7l7xN8di-NLt_hDtnsfkmzvNCBLU91sL1zVmngut1fgVZHSNsW0AsAsDFDkdeTqwqS-iZwMcQSVC9lflfljv9F2FFj7f_fNlzanq4mTV6KnYVOabpCbHZqkO636b5Frvr5N1g-6ePkd8gMZmky4V0RN7SgmktOuxA6dV_TzzNX-nCIA9LSL1dBZTRdDWS8K_sZRHv_89l3F9BzsAjqeOhTaR67nL_6EYpHdZUMDU-0ramiYKluFJC8c3sXTGG6arpXER6zmIcG-pnuwZd4lR9O3Hye7rKvPwKyMVcOKvLReGThyVXFZxiZzvgJ8KBxgTq4yWwBUSjmWRyos6MJxh0zgiXN5ksBXm90jazXM7wGh3MjCyzxW0jqeV7FJKs95hWVBjFLKRiTp1aRtR16ONTROdTjE5FK3qtWgWh1Uq79G5MXQZ9FSd_xT-jVqf5BE2u3ww3z5SXdWrIVJfSKsL_GvdOk5wCkuASOVRebgHKgi8hzXjkbnAMOzprvjAJNEmi29A_5U5njGjMjWSBKM2o6b-9WnO6ey0qkSAt-I4hF5OjRjT0yUq_38LMggoU4i8ojcbxfrMKVMigzwZRoRNVrGozmPW-rZSaAcB9DKuYoj8rJf8BfD-vs7ffh_4k_I-oc3U_1-73B_k9xI0UoT-BRbZK1ZnvlHgP6a8nEw8F-AA1Sf |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence+and+risk+factors+of+kidney+stone+disease+in+population+aged+40%E2%80%9370+years+old+in+Kharameh+cohort+study%3A+a+cross-sectional+population-based+study+in+southern+Iran&rft.jtitle=BMC+urology&rft.au=Leila+Moftakhar&rft.au=Fatemeh+Jafari&rft.au=Masoumeh+Ghoddusi+Johari&rft.au=Ramin+Rezaeianzadeh&rft.date=2022-12-19&rft.pub=BMC&rft.eissn=1471-2490&rft.volume=22&rft.issue=1&rft.spage=1&rft.epage=9&rft_id=info:doi/10.1186%2Fs12894-022-01161-x&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_5a2e15ceb23046e481946181b93d6667 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2490&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2490&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2490&client=summon |